Navigation
Markedsudsigter Stock Screener Udbyttekalender Begivenhedskalender Bedømmelse af aktier Markedsnyheder
Prøv gratis

Agile Therapeutics

NASDAQ AGRX
$0.37 0.0000 0.0000%
I dag aktiekurs
USA
Sektor: Sundhedspleje Industri: Lægemidler
Få adgang
til vurderingen af ​​Finrange-aktier
Med denne takst vil du være i stand til at bruge tjenesten uden begrænsninger, al information vil være tilgængelig
Få 7 dage gratis

Bedømmelse Finrange

Indeks: 18 %
Market cap

Markedsværdi - refererer til den samlede værdi af alle en virksomheds aktier. Det beregnes ved at gange prisen på en aktie med dens samlede antal udestående aktier.
1.74B
EV

Virksomhedsværdi er et mål for en virksomheds samlede værdi, ofte brugt som et mere omfattende alternativ til aktiemarkedsværdi. Enterprise value omfatter i sin opgørelse markedsværdien af ​​en virksomhed, men også kortfristet og langfristet gæld samt eventuelle kontanter på virksomhedens balance.
1.74B
Beta

Beta er en af ​​de mest populære indikatorer for risiko er et statistisk mål. Analytikere bruger ofte dette mål, når de skal bestemme en akties risikoprofil.
1.02
Shares

Udestående aktier refererer til et selskabs aktier, der i øjeblikket ejes af alle dets aktionærer, herunder aktieblokke, der ejes af institutionelle investorer og begrænsede aktier, der ejes af selskabets insidere.
4.63B
YTD

År til dato (YTD) refererer til den periode, der begynder den første dag i det aktuelle kalenderår eller regnskabsår op til den aktuelle dato. akronymet ændrer ofte begreber som investeringsafkast og prisændringer.
-80.77 %

Kommende arrangementer Agile Therapeutics

Alle arrangementer
Ingen kommende begivenheder planlagt

Oversigt

Økonomi

Nøglemålinger

Udbytte

Brancheoversigt

Begivenheder

Aktiediagram Agile Therapeutics

Aktieanalyse Agile Therapeutics

Indikator Selskab Industri
P/E (LTM)

Viser, hvor mange år investorens investering i virksomheden vil betale sig med overskud over de sidste 12 måneder.
-222.80 83.54
P/BV (LTM)

Viser forholdet mellem aktiens markedspris og den aktuelle bogførte værdi.
-106.42 11.34
EV/EBITDA (LTM)

Repræsenterer forholdet mellem virksomhedens værdi og dets EBITDA før skat i de seneste 12 måneder.
-111.17 298.70
Net Debt/EBITDA (LTM)

En virksomheds gældsgrad, som angiver, hvor længe virksomheden skal køre på cash flow inden for de seneste 12 måneder for at betale sin egen gæld.
0.03 -3.52
ROE (LTM)

Viser effektiviteten af ​​at bruge selskabets aktiekapital. Med andre ord viser ROE hvor stor en del af virksomhedens nettooverskud for den investerede kapital over de sidste 12 måneder.
75.49 11.67

Prisændring Agile Therapeutics pr år

0.91$ 3.77$
Min Maks

Sammenfattende analyse Agile Therapeutics

Få adgang
til vurderingen af ​​Finrange-aktier
Med denne takst vil du være i stand til at bruge tjenesten uden begrænsninger, al information vil være tilgængelig
Få 7 dage gratis

Aktionærstruktur Agile Therapeutics

Omsætning og nettoindtægt Agile Therapeutics

Alle parametre

Aktienyheder Agile Therapeutics

Alle nyheder
22 marts 2023 в 23:56

Agile Therapeutics Shares Surge 25% on Narrower Loss, Rev Boost

27 april 2022 в 20:40

Agile Therapeutics Shares Down 29% After Reverse Stock Split

27 april 2022 в 20:35

Agile Therapeutics Shares Down 29% After Reverse Stock Split

8 oktober 2021 в 20:30

Agile Therapeutics Shares Drop 29% After Public Stock Offering Prices

8 oktober 2021 в 20:25

Agile Therapeutics Shares Drop 29% After Public Stock Offering Prices

8 oktober 2021 в 15:50

Agile Therapeutics Prices Public Offering of Shares, Warrants

8 oktober 2021 в 15:50

Agile Therapeutics Prices Public Offering of Shares, Warrants

8 oktober 2021 в 00:45

Agile Therapeutics Plans Underwritten Public Offering, Shares 19% Lower

8 oktober 2021 в 00:45

Agile Therapeutics Plans Underwritten Public Offering, Shares 19% Lower

20 august 2021 в 17:59

Agile Therapeutics Works with Telehealth Service to Increase Women's Access to Twirla

20 august 2021 в 17:59

Agile Therapeutics Works with Telehealth Service to Increase Women's Access to Twirla

2 august 2021 в 18:49

Agile Therapeutics stock price target cut to $4 from $6 at Maxim

Om virksomheden Agile Therapeutics

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Adresse:
101 Poor Farm Road, Princeton, NJ, United States, 08540
Firmanavn: Agile Therapeutics
Udsteder ticker: AGRX
ISIN: US00847L1008
Land: USA
Udveksle: NASDAQ
betalingsmiddel: $
IPO datoer: 2014-05-23
Sektor: Sundhedspleje
Industri: Lægemidler
websted: https://www.agiletherapeutics.com

On which stock exchange are Agile Therapeutics (AGRX) stocks traded?

Agile Therapeutics (AGRX) stocks are traded on NASDAQ.

What is the ticker of Agile Therapeutics stocks (AGRX)?

The stock ticker of Agile Therapeutics’s stocks or in other words, the code is AGRX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Agile Therapeutics (AGRX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Agile Therapeutics (AGRX) belongs to the «Sundhedspleje» sector and the «Lægemidler» industry.

In what currency are Agile Therapeutics (AGRX) stocks traded?

Agile Therapeutics (AGRX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Agile Therapeutics (AGRX) stocks today?

The current price of Agile Therapeutics stocks on 27.05.2024 is 0.3749 dollars. per share.

What is the dynamics of Agile Therapeutics (AGRX) stocks from the beginning of the year?

Agile Therapeutics (AGRX) quotes have increased by -79.63% from the beginning of the year up to 0.3749 dollars. per 1 stocks.

How much did Agile Therapeutics (AGRX) stocks increase in мае 2024?

This month Agile Therapeutics (AGRX) quotes have increased by -14.7% to 0.3749 dollars. per share.

How much are Agile Therapeutics (AGRX) stocks worth?

Today, on October, 27.05.2024 Agile Therapeutics’s (AGRX) stocks cost 0.3749 dollars..

What is the market capitalization of Agile Therapeutics (AGRX)?

Capitalization is the market value of Agile Therapeutics (AGRX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 27.05.2024, the market capitalization of Agile Therapeutics (AGRX) is estimated at about 1736500060 dollars.